Breaking News, Promotions & Moves

Icagen, Inc.

Seth V. Hetherington, M.D., senior vice president of Clinical and Regulatory Affairs at Icagen, Inc., will be leaving the company at the end of the year.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Seth V. Hetherington, M.D., senior vice president of Clinical and Regulatory Affairs at Icagen, Inc., will be leaving the company at the end of the year. Greg C. Rigdon, Ph.D., vice president, New Product Development, will assume Dr. Hetherington’s role, taking on responsibility for the company’s clinical development efforts. P. Kay Wagoner, chief executive officer of Icagen, said, “Dr. Hetherington has provided outstanding leadership to Icagen’s clinical development efforts...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters